Pamrevlumab
Pamrevlumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Pamrevlumab is under investigation in clinical trial NCT00913393 (Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy).
Trade Name | Pamrevlumab |
Generic | Pamrevlumab |
Pamrevlumab Other Names | Pamrevlumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pamrevlumab